muscarinic M4 positive allosteric modulators (AstraZeneca)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namemuscarinic M4 positive allosteric modulators (AstraZeneca)
Drug Alias NameAZ-123
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M4 modulators
TargetsMuscarinic acetylcholine receptor M4
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A